Smell tests are used to diagnose diseases involving loss of smell. However, the standard smell tests available in the market are expensive, not widely available, and often require a lot of time to administer in regular healthcare settings. Researchers from the Queen Mary University of London have recently developed a novel smell test that can be easily administered and can be used for rapid diagnosis of chronic neurological conditions, and COVID-19, which affects the sense of smell. The novel smell testing kit has been developed to diagnose certain chronic neurological conditions, like Alzheimer's and Parkinson’s diseases characterized by loss of smell.
This kit could be used to diagnose respiratory diseases like COVID-19. The smell testing kit consists of capsules containing aromatic oils placed between two strips of single-sided tape. The capsules need to be crushed between the…
